Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
The FDA is going forward with an investigation into the safet | The FDA is going forward with an investigation into the safety of the abortion pill mifepristone, an initiative that could allow the Trump administration to impose restrictions on its use, The Wall Street Journal reports.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

FDA Launches Study Of Abortion Pill Safety, WSJ Reports

FDA launches safety study for abortion pill mifepristone, source says

Report: FDA just launched a study on the abortion pill

FDA launches study of abortion pill safety, WSJ reports

FDA Opens Safety Study Into Mifepristone After Pressure From Anti-Abortion Groups, Report Says

FDA launches safety study of abortion pill Mifepristone | The Jerusalem Post

FDA Launches Study of Abortion Pill Safety as Opponents Push for Limits

RFK Jr’s FDA launches study of the safety of the abortion pill mifepristone: Report

Inaction has consequences: Mail-order mifepristone is midterm game-changer

The full results are unlikely to be completed before November's midterm elections, the report said.

The Food and Drug Administration has launched a safety study of the abortion pill mifepristone, a senior FDA official confirmed…

The FDA's ongoing review of mifepristone could skip over established science, health experts warn

Regulators maintain that the medication remains safe when used as directed

The reported study could allow the Trump administration to limit the distribution of the abortion pill by mail or telehealth…

The U.S. | The U.S. Supreme Court has issued an emergency order, temporarily blocking a federal appeals court ruling in Louisiana…